Company logo

HCSG - Healthcare Services Group, Inc.

NASDAQ -> Healthcare -> Medical Care Facilities
Bensalem, United States
Type: Equity

HCSG price evolution
HCSG
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $54.33 $31.31 $28.66 $16.15
Short term investments $93.13 $90 $93.19 $95.98
Net receivables $383.51 $367.81 $380.06 $350.78
Inventory $18.48 $19.19 $19.98 $20.23
Total current assets $571.7 $533.36 $549.09 $510.09
Long term investments $24.83 $28.77 $30.74 $32.33
Property, plant & equipment $28.77 $29.14 $26.93 $23.4
Goodwill & intangible assets $87.66 $88.33 $89.07 $90.27
Total noncurrent assets $218.96 $217.35 $212.67 $209.05
Total investments $117.96 $118.77 $123.92 $128.31
Total assets $790.65 $750.72 $761.76 $719.13
Current liabilities
Accounts payable $83.22 $70.58 $65.62 $64.35
Deferred revenue
Short long term debt $25 $45 $40 $35
Total current liabilities $216.93 $187.77 $189.66 $162.16
Long term debt $11.23 $11.64 $11.56 $8.59
Total noncurrent liabilities $117.11 $121.21 $121.5 $116.4
Total debt $36.23 $56.65 $51.56 $43.59
Total liabilities $334.04 $308.98 $311.17 $278.56
Shareholders' equity
Retained earnings $185.01 $170.3 $175.79 $167.19
Other shareholder equity -$1.84 -$4.78 -$3.13 -$2.27
Total shareholder equity $456.62 $441.73 $450.59 $440.57
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $54.33 $26.28 $70.79 $139.33
Short term investments $93.13 $95.2 $114.4 $125.01
Net receivables $383.51 $343.41 $293.39 $255.47
Inventory $18.48 $21.16 $26.02 $31.59
Total current assets $571.7 $508.63 $546.38 $572.4
Long term investments $24.83 $32.61 $29.26 $34.42
Property, plant & equipment $28.77 $22.98 $28.1 $26.56
Goodwill & intangible assets $87.66 $91.47 $95.56 $69.27
Total noncurrent assets $218.96 $209.7 $231.15 $212.63
Total investments $117.96 $127.81 $143.66 $159.43
Total assets $790.65 $718.33 $777.53 $785.03
Current liabilities
Accounts payable $83.22 $68.3 $64.42 $52.24
Deferred revenue
Short long term debt $25 $25
Total current liabilities $216.93 $178.62 $191.13 $162.26
Long term debt $11.23 $8.1 $11.3 $11.36
Total noncurrent liabilities $117.11 $113.54 $133.73 $142.31
Total debt $36.23 $33.1 $11.3 $11.36
Total liabilities $334.04 $292.16 $324.85 $304.57
Shareholders' equity
Retained earnings $185.01 $154.5 $183.96 $200.89
Other shareholder equity -$1.84 -$3.48 $4 $5.56
Total shareholder equity $456.62 $426.17 $452.68 $480.46
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $423.84 $411.39 $418.93 $417.23
Cost of revenue $350.38 $377.55 $367.73 $360.98
Gross Profit $73.46 $33.83 $51.2 $56.25
Operating activities
Research & development
Selling, general & administrative $46.25 $39.05 $41.43 $40.05
Total operating expenses $46.25 $39.05 $41.43 $40.05
Operating income $27.21 -$5.21 $9.77 $16.2
Income from continuing operations
EBIT $33.1 -$4.82 $13.32 $19.31
Income tax expense $8.44 -$1.46 $2.81 $4.87
Interest expense $2.06 $2.13 $1.92 $1.75
Net income
Net income $22.6 -$5.49 $8.6 $12.68
Income (for common shares) $22.6 -$5.49 $8.6 $12.68
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $1671.39 $1690.18 $1641.96 $1760.3
Cost of revenue $1456.64 $1496.34 $1415.08 $1492.32
Gross Profit $214.75 $193.84 $226.88 $267.99
Operating activities
Research & development
Selling, general & administrative $166.77 $140.34 $173.11 $150.78
Total operating expenses $166.77 $140.34 $173.11 $150.78
Operating income $47.97 $53.5 $53.77 $117.21
Income from continuing operations
EBIT $60.91 $48.07 $63.21 $130.56
Income tax expense $14.67 $10.45 $15.96 $30.5
Interest expense $7.86 $2.99 $1.39 $1.37
Net income
Net income $38.39 $34.63 $45.86 $98.68
Income (for common shares) $38.39 $34.63 $45.86 $98.68
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income $22.6 -$5.49 $8.6 $12.68
Operating activities
Depreciation $3.78 $3.25 $3.6 $3.72
Business acquisitions & disposals
Stock-based compensation $2.19 $2.38 $2.35 $2.06
Total cash flows from operations $49.45 $2.94 $7.4 -$16.29
Investing activities
Capital expenditures -$1.43 -$1.84 -$1.06 -$0.95
Investments $0.05 $0.57 $1.17 $0.21
Total cash flows from investing -$1.38 -$1.27 $0.11 -$0.74
Financing activities
Dividends paid
Sale and purchase of stock -$5.04 -$4.02 -$2.22
Net borrowings -$20 $5 $5 $10
Total cash flows from financing -$25.05 $0.98 $5 $6.91
Effect of exchange rate
Change in cash and equivalents $23.02 $2.65 $12.51 -$10.13
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $38.39 $34.63 $45.86 $98.68
Operating activities
Depreciation $14.34 $15.32 $14.67 $14.27
Business acquisitions & disposals -$0.11 -$23.88
Stock-based compensation $8.98 $9.21 $8.83 $7.87
Total cash flows from operations $43.5 -$8.17 $37.11 $217.21
Investing activities
Capital expenditures -$5.29 -$4.82 -$5.48 -$4.07
Investments $1.99 $7.51 $6.36 -$32.78
Total cash flows from investing -$3.29 $2.58 -$22.99 -$36.84
Financing activities
Dividends paid -$63.37 -$62.23 -$60.7
Sale and purchase of stock -$11.28 $0.52 -$19.02 $3.01
Net borrowings $25 -$10
Total cash flows from financing -$12.15 -$38.93 -$82.65 -$68.37
Effect of exchange rate
Change in cash and equivalents $28.05 -$44.52 -$68.54 $112
Fundamentals
Market cap $918.96M
Enterprise value $900.87M
Shares outstanding 73.34M
Revenue $1.67B
EBITDA $75.26M
EBIT $60.91M
Net Income $38.39M
Revenue Q/Q -0.04%
Revenue Y/Y N/A
P/E ratio 23.94
EV/Sales 0.54
EV/EBITDA 11.97
EV/EBIT 14.79
P/S ratio 0.55
P/B ratio 2.00
Book/Share 6.25
Cash/Share 0.74
EPS $0.52
ROA 5.08%
ROE 8.58%
Debt/Equity 0.73
Net debt/EBITDA 3.72
Current ratio 2.64
Quick ratio 2.55